 NEW YORK, Sept. 29, 2021 GLOBE NEWSWIRE -- LifeMD, Inc . the Company NASDAQ: LFMD, a leading direct-to-patient telehealth company, today announced the pricing of its previously announced underwritten registered public offering of 3,333,334 shares of its common stock, par value 0.01 per share, for gross proceeds of approximately 20 million at a public offering price of 6.00 per share of common stock, prior to deducting underwriting discounts and commissions and estimated offering expenses. In connection with this offering, the Company has granted the underwriters a 30-day option to purchase 500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on October 4, 2021, subject to customary closing conditions. 